A health ministry panel Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese ...

Lecanemab and donanemab effects lasting over three years, new treatments, trials of home injections and blood tests for ...

Seven years of investigation by scientists at Harvard Medical School has revealed that the loss of the metal lithium plays a ...

A Japanese health ministry panel on Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and US industry peer Biogen Inc., by 15 ...

Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding ...

A Harvard team reverses dementia in mice with a metal supplement, after showing that its deficiency drives the disease ...

Lithium could help treat cases of Alzheimer’s disease, a Harvard study suggests. People with the neurodegenerative condition have low levels of the metal in their brain which the study revealed, for ...

Why does the brain of some people stay sharp into their 80s and beyond? An expert explains what 25 years of exploring the ...